X-50308530-G-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_033031.3(CCNB3):āc.361G>Cā(p.Val121Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000225 in 1,202,608 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 9 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_033031.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCNB3 | NM_033031.3 | c.361G>C | p.Val121Leu | missense_variant | 6/13 | ENST00000376042.6 | NP_149020.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCNB3 | ENST00000376042.6 | c.361G>C | p.Val121Leu | missense_variant | 6/13 | 2 | NM_033031.3 | ENSP00000365210 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000180 AC: 2AN: 111381Hom.: 0 Cov.: 23 AF XY: 0.0000298 AC XY: 1AN XY: 33595
GnomAD3 exomes AF: 0.00000583 AC: 1AN: 171617Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 57629
GnomAD4 exome AF: 0.0000229 AC: 25AN: 1091227Hom.: 0 Cov.: 30 AF XY: 0.0000224 AC XY: 8AN XY: 357325
GnomAD4 genome AF: 0.0000180 AC: 2AN: 111381Hom.: 0 Cov.: 23 AF XY: 0.0000298 AC XY: 1AN XY: 33595
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 18, 2024 | The c.361G>C (p.V121L) alteration is located in exon 5 (coding exon 4) of the CCNB3 gene. This alteration results from a G to C substitution at nucleotide position 361, causing the valine (V) at amino acid position 121 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at